The next focusIR Investor Webinar takes places on 14th May with guest speakers from Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksBk. Cyprus Hldg Regulatory News (BOCH)

Share Price Information for Bk. Cyprus Hldg (BOCH)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 355.00
Bid: 350.00
Ask: 354.00
Change: 8.00 (2.31%)
Spread: 4.00 (1.143%)
Open: 350.00
High: 355.00
Low: 346.00
Prev. Close: 347.00
BOCH Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Changes to the Group's Provisioning Assumptions

21 Aug 2017 16:38

RNS Number : 5845O
Bank of Cyprus Holdings PLC
21 August 2017
 

Announcement

 

Nicosia, 21 August 2017

 

 

 

Important Changes to the Group's Provisioning Assumptions

Bank of Cyprus Holdings Public Limited Company (together with Bank of Cyprus Public Company Limited, the "Bank", and its subsidiaries, the "Group") has decided to make certain modifications to its provisioning assumptions and estimates. These changes reinforce the prudential safety of the Group's balance sheet and, ceteris paribus, position the Group to present more normal results into 2018 and beyond.

These changes reflect the Group's reconsideration of its strategy, to more actively explore other innovative strategic solutions to further accelerate balance sheet de-risking and take into consideration the on-going discussion with its supervisor, the European Central Bank ("ECB"), in context of the 2017 Supervisory Evaluation & Review Process ("SREP").

One of the key modifications to be made is the introduction of further discounts in addition to those on the recoverable value of collateral, as well as the prolongation of the assumed time taken to recover this collateral. In modifying its provisioning assumptions, the Group has given consideration to its strategy for reducing delinquent loans, as well as other available evidence. The changes being adopted reflect an increased level of conservatism within an acceptable range and are expected to position cash coverage levels near 50% of non-performing exposures (as per the European Banking Authority's definition, "NPEs").

These changes are expected to result in increased provisions of c.€500 mn in excess of previous guidance and in a reduction in the level of Deferred Tax Assets (DTA) of c.€60 mn. The Group intends to reflect these incremental adjustments in its First Half 2017 Financial Results to be announced on 29 August 2017.

Previously, the Group had guided that it anticipated a near-zero result for the full year with its operating profits being utilised to support further balance sheet de-risking. As a result of these changes to provisioning assumptions and the consequential additional provision charge, the Group expects to announce First Half 2017 Financial Results with a loss of c.€550 mn. In line with previous guidance, the Group expects its operating profits in the second half of 2017 to be utilised to further de-risk its balance sheet.

As a result of the increased balance sheet provisions, the provision coverage level on NPEs as at 30 June 2017 is expected to increase to c.48%1 from c.42% as at 31 March 2017. The Group's

Common Equity Tier 1 (CET1) ratio and Total Capital ratio as at 30 June 2017 (transitional basis) are expected to be reduced to c.12.3%1and c.13.7%1, respectively, but they will continue to be in excess

of the current regulatory minimum requirements of 9.5% and 13.0%, respectively.

For the past four quarters, the Group has utilised substantially all its ongoing operating profits to the de-risking of its balance sheet and this was expected to continue for some quarters to come. The decision the Group is taking today represents a significant acceleration of this strategy and concludes the Group's active and ongoing dialogue with the ECB on this matter. This is expected to allow the Group, all other things being equal, to return to a more normal level of performance in 2018, reflecting a more conventional credit charge each quarter going forward, whilst maintaining safe levels of regulatory capital and buffers to achieve other business and de-risking objectives.

Preliminary Assessment of the impact of IFRS 9

The Group continues to develop its processes to enable IFRS 9 to be implemented on 1 January 2018. The Group expects to be in a position to provide a robust estimate on the effect on its CET1 ratio later this year, when the implementation programme, validation and testing is further advanced. The capital impact of any opening IFRS 9 adjustment to the provision stock is expected to be largely phased-in over a five year period in line with the proposal of the Council of the European Union2 .The

Group expects that the IFRS 9 adjustment will further improve coverage levels to in excess of 50% and is expected to be sensibly accommodated in the 2017 SREP decision. The effect of introducing IFRS 9 on CET1 in 2018 is expected to be small on a phased-in basis. The Group expects the phased-in fully-loaded impact of IFRS 9 to be manageable within its capital plans.

Regulatory Capital

The Group believes that it can accommodate both the changes in its provisioning assumptions and the estimated phased-in impact of IFRS 9 within its current CET1 capital. This is predicated on the ECB's 2017 SREP decision taking account of these deliberate and decisive adjustments and the implementation of the currently proposed IFRS 9 transitional reliefs.

The Group does not expect to have to raise any further equity in the form of Common Equity Tier 1 and expects its post-adjustment equity position to be satisfactory to its supervisors. The Group expects to re-build further strength in its CET1 capital base in 2018 through posting results which reflect a more conventional credit- credit cost.

In January 2017, the Group raised €250 mn of Tier 2 capital. The Group will continue, subject to market conditions, to examine opportunities to raise additional Tier 2 and/or AT1 bonds in the next 12 months. This will further strengthen the Group's capital base well ahead of Minimum Required Eligible Liabilities ("MREL") and create greater versatility into the future.

The Group expects to continue to be able to support the recovery of the Cyprus economy through the provision of new lending.

 

For further information, please contact Investor Relations at investors@bankofcyprus.com.

 

 

 

 

 

 

 

 

 

 

Bank of Cyprus Group Profile

 

The Bank of Cyprus Group is the leading banking and financial services group in Cyprus, providing a wide range of financial products and services which include retail and commercial banking, finance, factoring, investment banking, brokerage, fund management, private banking, life and general insurance. The Bank of Cyprus Group operates through a total of 126 branches, of which 121 operate in Cyprus, 1 in Romania and 4 in the United Kingdom. Bank of Cyprus also has representative offices in Russia, Ukraine and China. The Bank of Cyprus Group employs 4,302 staff worldwide. At 31 March 2017, the Group's Total Assets amounted to €22.5 bn and Total Equity was €3.1 bn. The Bank of Cyprus Group comprises Bank of Cyprus Holdings Public Limited Company, its subsidiary Bank of Cyprus Public Company Limited and its subsidiaries.

 


1 Pro forma numbers based on provisional 30 June 2017 figures

 

 

2 Proposal for a Regulation of the European Parliament and of the Council amending Regulation (EU) No 575/2013 as regards the transitional period for mitigating the impact on own funds of the introduction of IFRS 9 and the large exposures treatment of certain public sector exposures denominated in non-domestic currencies of Member States http://data.consilium.europa.eu/doc/document/ST-9480-2017-INIT/en/pdf

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
MSCFMGZRKMGGNZM
Date   Source Headline
9th May 20247:00 amRNSBOCH - Transactions in Own Shares
8th May 20247:06 amRNSTransaction in Own Shares
2nd May 20247:28 amRNSBOCH - Transactions in Own Shares
2nd May 20247:20 amRNSBOCH – Total voting rights and Capital
30th Apr 202410:19 amRNSAppointments of New Directors
30th Apr 20247:02 amRNSTransaction in Own Shares
29th Apr 20247:15 amRNSBOCH - Transactions in Own Shares
26th Apr 20241:21 pmRNSDate of announcement of 1Q2024 FR
26th Apr 20247:03 amRNSBOCH - Transactions in Own Shares
25th Apr 20247:26 amRNSBOCH - Transactions in Own Shares
25th Apr 20247:00 amRNSIssue of Green Senior Preferred Notes by BOC PCL
24th Apr 20247:00 amRNSBOCH - Transaction in Own Shares
24th Apr 20247:00 amRNSTR1 Notification - Helikon
24th Apr 20247:00 amRNSTR1 Notification -Helikon
23rd Apr 20247:25 amRNSBOCH - Transactions in Own Shares
22nd Apr 20247:27 amRNSBOCH - Transactions in Own Shares
19th Apr 20247:41 amRNSLaunch of share buyback programme
12th Apr 202410:02 amRNSNotice of AGM
5th Apr 20247:20 amRNS2023 Pillar 3 Disclosures
2nd Apr 20241:21 pmRNSTR1 Notification of Holdings - OSOME
2nd Apr 202412:59 pmRNSTR1 Notification of Holdings - OSOME
28th Mar 20242:24 pmRNSBOC Annual Financial Report 2023 Announcement
28th Mar 20241:31 pmRNSBOCH Annual Financial Report 2023 Announcement
28th Mar 20241:30 pmRNSFY2023 Investor Presentation Announcement
28th Mar 20241:30 pmRNSFY2023 Group Financial Results
20th Mar 20247:00 amRNSAnnouncement of Distribution
15th Mar 20249:21 amRNSDate of Announcement of Audited FY2023 FS
19th Feb 20247:01 amRNSDoc re. (Prelim FY2023 Investor Presentation)
19th Feb 20247:00 amRNSPreliminary FY2023 Group Financial Results
6th Feb 20248:41 amRNSDate of announcement of Preliminary FY2023 FR
22nd Dec 20239:09 amRNSRevised Date of AGM
20th Dec 20238:32 amRNSChanges in the composition of the BOD & Committees
13th Dec 20237:00 amRNSEU-wide Transparency Exercise 2023
11th Dec 20232:51 pmRNSChanges in the composition of the BOD
29th Nov 202310:28 amRNSDecision to call AT1 Capital Securities
29th Nov 20238:19 amRNSDate of Annual General Meeting
20th Nov 20239:58 amRNSAppointment of New Director
13th Nov 20237:00 amRNSDoc re. (9M2023 Investor Presentation)
13th Nov 20237:00 amRNS9M2023 Group Financial Results
27th Oct 20237:17 amRNSDate of announcement of 9M2023 FR
24th Oct 202312:41 pmRNSTR1 Notification - Caius
13th Oct 202312:27 pmRNSChanges in the composition of the BODs
27th Sep 20238:28 amRNSDirectorate Change
31st Aug 20237:37 amRNSChanges in the composition of BOD
11th Aug 20239:55 amRNSAppointment of new director
21st Jul 202310:43 amRNSDate of announcement of 1H2023 FR
18th Jul 20234:43 pmRNSIssue of Senior Preferred Notes
3rd Jul 202311:48 amRNSBuyback of Additional Tier 1 Capital Securities
23rd Jun 202312:48 pmRNSComposition of the Boards of Directors
20th Jun 202312:22 pmRNSResults of Additional Tier 1 Tender Cash Offer

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.